|
May 9
|
Kamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
|
|
May 1
|
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
|
|
Mar 13
|
KMDA: Double Digit Growth Anticipated in 2024 with $158 Million in Expected Revenues and $28 Million in Expected Adjusted EBITDA…
|
|
Mar 7
|
Kamada Ltd. (NASDAQ:KMDA) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
Kamada Issues 2024 CEO Letter to Shareholders
|
|
Mar 6
|
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
|
|
Dec 7
|
KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®
|
|
Dec 7
|
KMDA: Amendment and Extension of Kedrab® U.S. Distribution Agreement to Generate at Least $180 Million Over First Four Years…
|
|
Dec 6
|
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
|
|
Aug 9
|
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023
|
|
Jul 12
|
Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB® Distribution Agreement in the U.S.
|